As a field, precision medicine holds great promise in the prevention and treatment of cancer. To date, oncology has the largest share of the precision medicine market, and its use is expected to grow another 12% by 2020.
A subset of precision medicine, pharmacogenomics, is also growing exponentially, especially in oncology. Currently, 165 drugs or combinations are influenced by pharmacogenetics, and 58 of those are specific to oncology/hematology.